1. Health
Send to a Friend via Email

Clinical Trial: Migraine, Zyprexa, PA, NCT00203307

By

Updated: July 13, 2006


Trial: Research Study Examining the Use of Olanzapine for the Prevention of Migraine.

Purpose: Olanzapine (o-lan-zah-peen) is a medication that has been approved by the Food and Drug Administration (FDA) for the treatment of patients with schizophrenia and/ or bipolar disorder. The trade name for this drug is Zyprexa®. Olanzapine has not been approved by the FDA for the prevention of migraine and is experimental for the purposes of this research study. The Jefferson Headache Center at Thomas Jefferson University has developed this clinical study to evaluate the safety and effectiveness of Olanzapine in preventing migraine headaches.

Condition: Migraine

Drug: Zyprexa

Device:

Procedure:

Trial Phase:

Official Title: Official Title: A Single-Site, Double-Blind, Placebo-Controlled Cross-Over Trial Examining the Safety and Efficacy of Olanzapine Taken Daily for the Prevention of Episodic Migraine.

Locations: PA

For more information: http://clinicaltrials.gov/show/NCT00203307

Related content:

______________
Source:
ClinicalTrials.gov
More Headaches & Migraines Quick Tips
  1. About.com
  2. Health
  3. Headaches & Migraines
  4. Clinical Trials
  5. U.S. Clinical Trials
  6. Clinical Trial: Migraine, Zyprexa, PA, NCT00203307 from About.com Headaches and Migraine

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.